Search results for: 'biologics products'

Global light vehicle production continued to expand moderately in 2025 despite ongoing economic uncertainty, shifting regulations, and the slowing transition toward electrification. This report examines how major automotive regions and OEM groups adapted to these pressures and restructured production strategies to remain competitive.While growth pa...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...

Electrolyzers use electrolysis to generate hydrogen from water. They are set to play a crucial role in the global transition towards clean energy, as they provide a sustainable and efficient method for producing low-/zero- carbon/hydrogen for various applications across sectors. Key factors contributing to the growth of the electrolyzer industry in...

Radical changes in science and technology are helping the human body evolve. Biological augmentations and body enhancements are transforming the human body and bringing about a kind of transhumanism by eliminating diseases, extending life spans, and enhancing human capabilities. Biological augmentations and body enhancements are classified into th...

The COVID-19 pandemic has exposed the frailty of the human body. Boosting immunity is now of primary importance to consumers post-pandemic, with many increasingly seeking food options that are nutritionally dense and provide multiple vitamins and minerals to improve health and body immunity. Superfoods have emerged as the ideal immunity-boosting so...

This research service considers the biologics market in Brazil. It covers the markets move toward greater regulation and outlines the impact of specific patent expirations. An analysis of monoclonal antibodies, blood factors, insulin, filgrastim, interferon, growth hormones, and erythropoietin is provided. This service also highlights key marke...

The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...

The Frost Radar on product lifecycle management (PLM) offers a competitive benchmark analysis derived from Frost & Sullivan s Global PLM Growth Opportunities study published in April 2024. It ranks 11 companies that best re?ect the PLM industry landscape on their growth potential and ability to innovate and disrupt. Global PLM industry revenue...

17 Jun 2021  |  North America  |  Market Research

Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities

Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential

Infographics

×

This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...